These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 9952387

  • 1. Qualitative and quantitative analysis of the local and systemic antibody response in mice and humans with Helicobacter immunity and infection.
    Blanchard TG, Nedrud JG, Reardon ES, Czinn SJ.
    J Infect Dis; 1999 Mar; 179(3):725-8. PubMed ID: 9952387
    [Abstract] [Full Text] [Related]

  • 2. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice.
    Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG.
    Cell Immunol; 1999 Jan 10; 191(1):74-80. PubMed ID: 9918689
    [Abstract] [Full Text] [Related]

  • 3. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
    Chomvarin C, Ottiwet O, Hahnvajanawong C, Intapan PM, Wongwajana S.
    Int J Infect Dis; 2009 Sep 10; 13(5):647-54. PubMed ID: 19233700
    [Abstract] [Full Text] [Related]

  • 4. Relationship between mucosal levels of Helicobacter pylori-specific IgA, interleukin-8 and gastric inflammation.
    Zhang QB, Etolhi G, Dawodu JB, Gemmell CG, Russell RI.
    Clin Sci (Lond); 1999 Apr 10; 96(4):409-14. PubMed ID: 10087249
    [Abstract] [Full Text] [Related]

  • 5. Antibody response to Helicobacter pylori excretory antigen and the cross reaction study.
    Sasidharan S, Uyub AM.
    J Immunoassay Immunochem; 2009 Apr 10; 30(1):70-81. PubMed ID: 19117203
    [Abstract] [Full Text] [Related]

  • 6. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C, Triantafilou K, Rasche FM, Möricke A, Vogt K, Triantafilou M, Hahn P, Schneider EM, Lepper PM.
    Int J Med Microbiol; 2006 Aug 10; 296(4-5):223-8. PubMed ID: 16600680
    [Abstract] [Full Text] [Related]

  • 7. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K, Kurtenkov O, von Mensdorff-Pouilly S, Shljapnikova L, Miljukhina L, Brjalin V, Lipping A.
    Immunol Invest; 2007 Aug 10; 36(4):371-86. PubMed ID: 17691020
    [Abstract] [Full Text] [Related]

  • 8. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization.
    Gottwein JM, Blanchard TG, Targoni OS, Eisenberg JC, Zagorski BM, Redline RW, Nedrud JG, Tary-Lehmann M, Lehmann PV, Czinn SJ.
    J Infect Dis; 2001 Aug 01; 184(3):308-14. PubMed ID: 11443556
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quantitative detection of secretory immunoglobulin A to Helicobacter pylori in gastric juice: antibody capture enzyme-linked immunosorbent assay.
    Hayashi S, Sugiyama T, Hisano K, Awakawa T, Kurokawa I, Yachi A, Isogai H, Isogai E, Yokota K, Hirai Y, Oguma K, Fujii N.
    J Clin Lab Anal; 1996 Aug 01; 10(2):74-7. PubMed ID: 8852358
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mice carrying a truncated Apc gene have diminished gastric epithelial proliferation, gastric inflammation, and humoral immunity in response to Helicobacter felis infection.
    Fox JG, Dangler CA, Whary MT, Edelman W, Kucherlapati R, Wang TC.
    Cancer Res; 1997 Sep 15; 57(18):3972-8. PubMed ID: 9307281
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model.
    Velin D, Favre L, Bernasconi E, Bachmann D, Pythoud C, Saiji E, Bouzourene H, Michetti P.
    Gastroenterology; 2009 Jun 15; 136(7):2237-2246.e1. PubMed ID: 19272385
    [Abstract] [Full Text] [Related]

  • 15. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients.
    Quiding-Järbrink M, Sundström P, Lundgren A, Hansson M, Bäckström M, Johansson C, Enarsson K, Hermansson M, Johnsson E, Svennerholm AM.
    Clin Immunol; 2009 Jun 15; 131(3):463-71. PubMed ID: 19249247
    [Abstract] [Full Text] [Related]

  • 16. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J, Adamsson J, Harandi AM.
    Scand J Immunol; 2008 May 15; 67(5):431-40. PubMed ID: 18298617
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.
    Malfertheiner P, Schultze V, Rosenkranz B, Kaufmann SH, Ulrichs T, Novicki D, Norelli F, Contorni M, Peppoloni S, Berti D, Tornese D, Ganju J, Palla E, Rappuoli R, Scharschmidt BF, Del Giudice G.
    Gastroenterology; 2008 Sep 15; 135(3):787-95. PubMed ID: 18619971
    [Abstract] [Full Text] [Related]

  • 20. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice.
    Taylor JM, Ziman ME, Huff JL, Moroski NM, Vajdy M, Solnick JV.
    Vaccine; 2006 Jun 05; 24(23):4987-94. PubMed ID: 16621176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.